ArticleNeuro-oncology2024

EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.

Biao Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.